Leaderboards/Atrial Fibrillation Management and Outcomes

Atrial Fibrillation Management and Outcomes

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Emmanuel Ekanem
Winchester Medical Center
2
Siyuan Cheng
First Affiliated Hospital of Jinan University
3
Miruna Popa
Deutsches Herzzentrum München
4
Maxim Grymonprez
Ghent University Hospital
5
Siyuan Tan
Central South University
6
Sanghamitra Mohanty
St David's Medical Center
7
Diego Mannhart
University Hospital of Basel
8
Eva Soler‐Espejo
University of Liverpool
9
Shota Tohoku
St. Josefskrankenhaus Freiburg
10
Jwan A. Naser
Mayo Clinic

Papers

1
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study
Nature Medicine|2024
412 cit.
2
Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2021
EP Europace|2024
194 cit.
3
Characterization and Clinical Significance of Hemolysis After Pulsed Field Ablation for Atrial Fibrillation: Results of a Multicenter Analysis
Circulation Arrhythmia and Electrophysiology|2024
100 cit.
4
Association between stress hyperglycemia ratio index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study using the MIMIC-IV database
Cardiovascular Diabetology|2024
61 cit.
5
Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046—a systematic analysis of the Global Burden of Disease Study 2021
EP Europace|2025
61 cit.
6
Publication in Heart Rhythm (2024) [49 citations, W4401371463]
Heart Rhythm|2024
49 cit.
7
Publication in European Heart Journal - Digital Health (2024) [44 citations, W4392180776]
European Heart Journal - Digital Health|2024
44 cit.
8
Publication in Journal of the American College of Cardiology (2024) [27 citations, W4393166234]
Journal of the American College of Cardiology|2024
27 cit.
9
Publication in European Heart Journal (2024) [27 citations, W4400308697]
European Heart Journal|2024
27 cit.
10
Publication in Heart Rhythm (2025) [25 citations, W4410698720]
Heart Rhythm|2025
25 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Christopher Toly
American Heart Association
2
Islamjan Sharipov
Interstate Commission for Water Coordination of Central Asia
3
Husniddin Kuchkarov
Tashkent Pediatric Medical Institute
4
Luis Aguinaga
Centro Científico Tecnológico - Tucumán
5
Ge Fulin
Unknown
6
Axel Loewe
Karlsruhe Institute of Technology
7
Dominik Linz
University of Copenhagen
8
T Pitt-Kerby
University of Belgrade
9
Thomas Pambrun
Université de Bordeaux
10
Mohamad Alkhouli
Mayo Clinic

Papers

1
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
European Heart Journal|2024
2.4k cit.
2
Atrial fibrillation: epidemiology, screening and digital health
The Lancet Regional Health - Europe|2024
385 cit.
3
Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion
JACC. Clinical electrophysiology|2022
172 cit.
4
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
EP Europace|2024
104 cit.
5
Transcatheter Edge-to-Edge Mitral Valve Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock
Journal of the American College of Cardiology|2022
82 cit.
6
Personalized ablation vs. conventional ablation strategies to terminate atrial fibrillation and prevent recurrence
EP Europace|2022
74 cit.
7
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
BMC Medicine|2022
70 cit.
8
Left Atrial Appendage Occlusion
JACC Advances|2022
70 cit.
9
90 vs 50-Watt Radiofrequency Applications for Pulmonary Vein Isolation: Experimental and Clinical Findings
Circulation Arrhythmia and Electrophysiology|2022
68 cit.
10
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe
Age and Ageing|2022
65 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Gregory Y.H. Lip
Medical University of Białystok
2
Lars Wallentin
Uppsala University
3
Andrea Natale
Texas Cardiac Arrhythmia
4
Daniel E. Singer
Massachusetts General Hospital
5
Katja Zeppenfeld
Leiden University Medical Center
6
Harry J.G.M. Crijns
University Medical Center
7
Robert M. Califf
Duke University
8
Salim Yusuf
Population Health Research Institute
9
Stanley Nattel
Montreal Heart Institute
10
Emelia J. Benjamin
Boston University

Papers

1
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
The Lancet|2004
12k cit.
2
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
New England Journal of Medicine|2009
11.2k cit.
3
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
New England Journal of Medicine|2011
9.4k cit.
4
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Circulation|2019
9.1k cit.
5
Apixaban versus Warfarin in Patients with Atrial Fibrillation
New England Journal of Medicine|2011
8.9k cit.
6
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
New England Journal of Medicine|2009
7.1k cit.
7
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
CHEST Journal|2009
6.7k cit.
8
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
EP Europace|2016
6.5k cit.
9
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
European Heart Journal|2016
6.4k cit.
10
Prevalence of Diagnosed Atrial Fibrillation in Adults
JAMA|2001
6.2k cit.

Reagents for Atrial Fibrillation Management and Outcomes

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling TechnologyEvidence 65

Tec (F2K5K) Rabbit Monoclonal Antibody

#99987$161,376
View Evidence →

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

ADAR1 (E6X9R) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

#99623$465
View Evidence →
Cell Signaling TechnologyEvidence 67

PA28 gamma Antibody

#2412$317
View Evidence →
Cell Signaling TechnologyEvidence 64

Aurora A (D3E4Q) Rabbit Monoclonal Antibody (PE Conjugate)

#50235$465
View Evidence →

🌟 All-Time

Most validated

InnoCytoEvidence 66

Anti-c-Myc Antibody

Cited in 15 papers
#300901
View Evidence →
Cell Signaling TechnologyEvidence 66

SHIP2 Antibody

Cited in 6 papers
#2730$317
View Evidence →
Cell Signaling TechnologyEvidence 67

Vimentin (D21H3) Rabbit Monoclonal Antibody (APC Conjugate)

Cited in 5 papers
#95159$465
View Evidence →